132
Participants
Start Date
October 31, 2007
Primary Completion Date
May 31, 2008
Study Completion Date
May 31, 2008
Ramelteon
Ramelteon 1 mg, tablets, orally, once daily for up to two weeks.
Ramelteon
Ramelteon 4 mg, tablets, orally, once daily for up to two weeks.
Ramelteon
Ramelteon 8 mg, tablets, orally, once daily for up to two weeks.
Placebo
Ramelteon placebo-matching tablets, orally, once daily for up to two weeks.
Birmingham
Tucson
Hot Springs
Little Rock
Fountain Valley
Glendale
Los Angeles
San Diego
Santa Monica
Tustin
Colorado Springs
Hallandale Bch
Naples
Pembroke Pines
South Miami
Spring Hill
St. Petersburg
Winter Park
Atlanta
Gainesville
Macon
Chicago
Danville
Overland Park
Topeka
Crestview Hills
Paducah
Chevy Chase
Newton
Hattiesburg
Lincoln
Las Vegas
New York
Raleigh
Salisbury
Cincinnati
Dublin
Toledo
Salem
Clarks Summit
Columbia
Austin
Lead Sponsor
Takeda
INDUSTRY